Loading clinical trials...

Assessing Vulnerability and Outcomes of Intracranial Atherosclerotic Plaques | Clinical Trials | Clareo Health

COMPLETEDNCT07156344

Assessing Vulnerability and Outcomes of Intracranial Atherosclerotic Plaques

This prospective cohort study aims to establish a large-scale cohort for primary stroke prevention in asymptomatic intracranial atherosclerosis (ICAS). Objectives include: characterizing risk factor a...

Lead sponsor: Xuanwu Hospital, Beijing•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment3,849

Start dateJan 2019

Last updatedSep 5, 2025

Condition

Asymptomatic Intracranial Atherosclerotic Stenosis Patients

Locations shown

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 5, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions